This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (24)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

National High Blood Pressure Education Program

Arch Intern Med. 1991;151(7):1280-1287.

Abstract
End-stage renal disease attributed to hypertension has increased annually for the last decade and will probably worsen through the year 2000. Patients with diabetic nephropathy and patients with hypertensive renal disease account for most new cases annually. Evidence reveals that all levels of untreated hypertension are associated with potentially declining renal function. Data from the Hypertension Detection and Follow-up Program and other studies show that antihypertensive treatment can prevent progressive renal failure. An ablation model demonstrates glomerular hyperfiltration as a possible mechanism for progressive renal failure. Human data on the renal effects of antihypertensive agents are limited and inconsistent. Despite the limitations, the Working Group on Hypertension and Chronic Renal Failure concludes that controlled hypertension to less than 140/90 mm Hg reduces the incidence of end-stage renal disease. Patients with established renal impairment may benefit from individualized treatment to 130/85 mm Hg or less.

(Arch Intern Med. 1991;151:1280-1287)

Author Affiliations
From the National High Blood Pressure Education Program.

Footnotes
Accepted for publication January 22, 1991.

Reprint requests to National High Blood Pressure Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892 (Edward J. Roccella, PhD, MPH, Coordinator).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats
Du et al.
Am. J. Physiol. Renal Physiol. 2009;297:F802-F808.
ABSTRACT | FULL TEXT  

The effects of an ACE inhibitor and a calcium antagonist on the progression of renal disease: the Nephros Study
Herlitz et al.
Nephrol Dial Transplant 2001;16:2158-2165.
ABSTRACT | FULL TEXT  

Prevalence of High Blood Pressure and Elevated Serum Creatinine Level in the United States: Findings From the Third National Health and Nutrition Examination Survey (1988-1994)
Coresh et al.
Arch Intern Med 2001;161:1207-1216.
ABSTRACT | FULL TEXT  

Current Strategies for Management of Hypertensive Renal Disease
Moore et al.
Arch Intern Med 1999;159:23-28.
ABSTRACT | FULL TEXT  

End-stage Renal Disease in Specific Ethnic and Racial Groups: Risk Factors and Benefits of Antihypertensive Therapy
Powers and Wallin
Arch Intern Med 1998;158:793-800.
ABSTRACT | FULL TEXT  

A New Classification Scheme for Hypertension Based on Relative and Absolute Risk With Implications for Treatment and Reimbursement
Black and Yi
Hypertension 1996;28:719-724.
ABSTRACT | FULL TEXT  

1995 Update of the Working Group Reports on Chronic Renal Failure and Renovascular Hypertension
National High Blood Pressure Education Program Wor
Arch Intern Med 1996;156:1938-1947.
ABSTRACT  

Early Predictors of 15-Year End-Stage Renal Disease in Hypertensive Patients
Perry et al.
Hypertension 1995;25:587-594.
ABSTRACT | FULL TEXT  

Angiotensin-Converting Enzyme Inhibitors in Hypertension: A Dozen Years of Experience
Materson and Preston
Arch Intern Med 1994;154:513-523.
ABSTRACT  

Projections of Hypertension-Related Renal Disease in Middle-aged Residents of the United States
Perneger et al.
JAMA 1993;269:1272-1277.
ABSTRACT  

Blood Pressure, Systolic and Diastolic, and Cardiovascular Risks: US Population Data
Stamler et al.
Arch Intern Med 1993;153:598-615.
ABSTRACT  

The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)
Arch Intern Med 1993;153:154-183.
ABSTRACT  

Can We Prevent End-Stage Renal Disease due to Hypertension or to Diabetes Mellitus?
Luke
JAMA 1992;268:3119-3120.
ABSTRACT